Interleukin-36: a novel therapeutic target for atherosclerosis.

Cardiovascular diseases remain the foremost cause of global morbidity and mortality, with atherosclerosis serving as the pathological basis for most related disorders. Despite the clinical benefits of statin therapy, a substantial residual risk persi…

Preview only. Read the full abstract at the source